XML 47 R15.htm IDEA: XBRL DOCUMENT v3.19.3
STOCK AWARD PLANS
 9 Months Ended
Sep. 30, 2019
STOCK AWARD PLANS [Abstract]  
STOCK AWARD PLANS
(8)  STOCK AWARD PLANS



The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statements of earnings for stock awards for the three months and nine months ended September 30, 2019 and 2018 were as follows (in thousands):


  
Three months ended September 30,
    
Nine months ended September 30,
  
   
2019
    
2018
    
2019
    
2018
  
Compensation cost
  
$
3,172
    
$
3,098
    
$
11,079
    
$
16,649
  
Income tax benefit
  
$
813
    
$
709
    
$
2,722
    
$
4,747
  


The Company has an employee stock award plan for selected officers and other key employees which provides for the issuance of stock options, restricted stock awards and performance awards. On February 19, 2018, the employee stock award plan was amended to also allow for the granting of restricted stock units (“RSUs”) to selected officers and other key employees. The amendment included a provision for the continued vesting of unvested stock options and RSUs for employees who meet certain years of service and age requirements at the time of their retirement. The vesting change resulted in shorter expense accrual periods on stock options and RSUs granted after February 19, 2018 to employees who are nearing retirement and meet the service and age requirements.


The exercise price for each option equals the fair market value per share of the Company’s common stock on the date of grant. Substantially all stock options outstanding under the plan have terms of seven years and vest ratably over three years. No performance awards payable in stock have been awarded under the plan. At September 30, 2019, 1,350,831 shares were available for future grants under the employee plan and no outstanding stock options under the employee plan were issued with stock appreciation rights.


The following is a summary of the stock option activity under the employee plan described above for the nine months ended September 30, 2019:


  
Outstanding
Non-
Qualified or
Nonincentive
Stock
Options
    
Weighted
Average
Exercise
Price
  
Outstanding at December 31, 2018
    
464,702
    
$
69.85
  
Granted
    
114,429
    
$
74.57
  
Exercised
    
(52,896
)
  
$
64.01
  
Canceled or expired
    
(16,498
)
  
$
72.56
  
Outstanding at September 30, 2019
    
509,737
    
$
71.43
  


The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at September 30, 2019:

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise
Prices
 
Number
Outstanding
 
 
Weighted
Average
Remaining
Contractual
Life in Years
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Number
Exercisable
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
$51.23
 
 
74,254
 
 
 
3.3
 
 
$
51.23
 
 
 
 
74,254
 
 
$
51.23
 
  
$64.65 - $68.50
    
100,757
      
4.7
    
$
67.34
        
45,433
    
$
68.43
    
$70.65 - $75.50
 
 
290,740
 
 
 
4.9
 
 
$
74.53
 
 
 
 
109,622
 
 
$
74.47
 
  
$84.90 - $101.46
 
 
43,986
 
 
 
2.1
 
 
$
94.38
 
 
 
 
37,281
 
 
$
96.08
 
  
$51.23 - $101.46
 
 
509,737
 
 
 
4.4
 
 
$
71.43
  
$6,007,000
 
 
266,590
 
 
$
69.99
  
$3,763,000


The following is a summary of the restricted stock award activity under the employee plan described above for the nine months ended September 30, 2019:


  
Unvested
Restricted
Stock
Award
Shares
    
Weighted
Average
Grant Date
Fair
Value
Per Share
  
Unvested balance at December 31, 2018
    
214,216
    
$
64.73
  
Vested
    
(62,723
)
  
$
68.29
  
Forfeited
    
(12,630
)
  
$
63.33
  
Unvested balance at September 30, 2019
    
138,863
    
$
63.26
  


The following is a summary of RSU activity under the employee plan described above for the nine months ended September 30, 2019:


  
Unvested RSUs
    
Weighted
Average Grant
Date Fair Value
Per Unit
  
Unvested balance at December 31, 2018
    
141,055
    
$
75.59
  
Granted
    
146,650
    
$
74.46
  
Vested
    
(25,484
)
  
$
75.60
  
Forfeited
    
(6,834
)
  
$
74.96
  
Unvested balance at September 30, 2019
    
255,387
    
$
74.96
  


The Company has a stock award plan for nonemployee directors of the Company which provides for the issuance of stock options and restricted stock awards. The director plan provides for automatic grants of restricted stock to nonemployee directors after each annual meeting of stockholders. In addition, the director plan allows for the issuance of stock options or restricted stock in lieu of cash for all or part of the annual director fee at the option of the director. The exercise prices for all options granted under the plan are equal to the fair market value per share of the Company’s common stock on the date of grant. The terms of the options are ten years. The restricted stock issued after each annual meeting of stockholders vests six months after the date of grant. Options granted and restricted stock issued in lieu of cash director fees vest in equal quarterly increments during the year to which they relate. At September 30, 2019, 462,342 shares were available for future grants under the director plan. The director stock award plan is intended as an incentive to attract and retain qualified independent directors.


The following is a summary of the stock option activity under the director plan described above for the nine months ended September 30, 2019:


  
Outstanding
Non-Qualified
or Nonincentive
Stock Options
    
Weighted
Average
Exercise Price
  
Outstanding at December 31, 2018
    
131,104
    
$
70.14
  
Granted
    
2,652
    
$
84.90
  
Exercised
    
(6,000
)
  
$
29.60
  
Outstanding at September 30, 2019
    
127,756
    
$
72.35
  


The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at September 30, 2019:

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise
Prices
 
Number
Outstanding
 
 
Weighted
Average
Remaining
Contractual
Life in Years
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Number
Exercisable
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
$41.24 – $56.45
 
 
31,276
 
 
 
1.2
 
 
$
50.61
 
 
 
 
31,276
 
 
$
50.61
 
  
$61.89 – $62.48
 
 
28,000
 
 
 
2.8
 
 
$
62.27
 
 
 
 
28,000
 
 
$
62.27
 
  
$70.65 – $99.52
 
 
68,480
 
 
 
4.6
 
 
$
86.39
 
 
 
 
67,154
 
 
$
86.42
 
  
$41.24 – $99.52
 
 
127,756
 
 
 
3.4
 
 
$
72.35
  
$1,790,000
 
 
126,430
 
 
$
72.22
  
$1,790,000


The following is a summary of the restricted stock award activity under the director plan described above for the nine months ended September 30, 2019:


  
Unvested
Restricted
Stock Award
Shares
    
Weighted
Average
Grant Date
Fair Value
Per Share
  
Unvested balance at December 31, 2018
    
264
    
$
85.30
  
Granted
    
21,064
    
$
84.90
  
Vested
    
(1,324
)
  
$
84.98
  
Unvested balance at September 30, 2019
    
20,004
    
$
84.90
  


The total intrinsic value of all stock options exercised under all of the Company’s plans was $1,003,000 and $6,709,000 for the nine months ended September 30, 2019 and 2018, respectively. The actual tax benefit realized for tax deductions from stock option exercises was $246,000 and $1,912,000 for the nine months ended September 30, 2019 and 2018, respectively. The total fair value of options vested was $1,910,000 and $3,170,000 during the nine months ended September 30, 2019 and 2018, respectively.


The total fair value of all the restricted stock vestings under all of the Company’s plans was $4,338,000 and $11,454,000 for the nine months ended September 30, 2019 and 2018, respectively. The actual tax benefit realized for tax deductions from restricted stock vestings was $1,066,000 and $3,264,000 for the nine months ended September 30, 2019 and 2018, respectively.


The total fair value of all the RSU vestings under the Company’s employee plan was $1,727,000 for the nine months ended September 30, 2019. The actual tax benefit realized for tax deductions from RSU vestings was $424,000 for the nine months ended September 30, 2019. There were no RSU vestings for the nine months ended September 30, 2018.


As of September 30, 2019, there was $2,812,000 of unrecognized compensation cost related to nonvested stock options, $5,527,000 related to nonvested restricted stock awards and $11,038,000 related to nonvested RSUs. The stock options are expected to be recognized over a weighted average period of approximately 1.5 years, restricted stock awards over approximately 1.5 years and RSUs over approximately 3.8 years.


The weighted average per share fair value of stock options granted during the nine months ended September 30, 2019 and 2018 was $22.77 and $23.53, respectively. The fair value of the stock options granted during the nine months ended September 30, 2019 and 2018 was $2,665,000 and $2,787,000, respectively. The Company currently uses treasury stock shares for restricted stock grants, RSU vestings, and stock option exercises. The fair value of each stock option was determined using the Black-Scholes option pricing model.



The key input variables used in valuing the options during the nine months ended September 30, 2019 and 2018 were as follows:



  
Nine months ended September 30,
  
   
2019
    
2018
  
Dividend yield
  
None
    
None
  
Average risk-free interest rate
    
2.5
%
    
2.7
%
Stock price volatility
    
28
%
    
27
%
Estimated option term
  
5.3 years
    
5.5 years